Phase 1Completed
Drug-drug Interaction Study of Rosuvastatin and AT-527 (R07496998)
A Phase 1, Open-Label Study to Evaluate the Effect of AT-527 on the Pharmacokinetics of Rosuvastatin in Healthy Adult Subjects
- Sponsor
- Atea Pharmaceuticals, Inc. (Industry)
- Enrollment
- 29 enrolled
- Conditions
- Healthy Volunteer Study
- Interventions
- Drug: AT-527 + rosuvastatin; AT-527 + rosuvastatin
- Ages
- adults, older adults
- Registry
- NCT05154123
Full record on ClinicalTrials.gov
From the registry
Drug-drug interaction study of rosuvastatin and AT-527 (R07496998)
Primary outcomes
- To evaluate the effect of co-administration of AT-527 on the single-dose pharmacokinetics (PK) of rosuvastatin
- To determine the effect of a staggered dose of AT-527 administered 2 hours before rosuvastatin on the PK of rosuvastatin
History
Last registry update
Primary completion
Registered
Started